How many clinical trials are tracked of ozanimod?

5 trials are tracked, 4 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

ozanimod

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of ozanimod

5 trials tracked of ozanimod: 4 in phase 3 or 4 and 4 with published results. The most-cited published study has 285 citations.

5Trials tracked

4Phase 3 & 4

0Recruiting

4With published results

Phase distribution

Phase 3 4 Phase 2 1

Phase 3 Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) Completed · 285 cited
Phase 3 Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis Completed · 279 cited
Phase 3 Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients Completed · 178 cited
Phase 3 Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease Completed · 30 cited
Phase 2 Efficacy and Safety Study of Ozanimod in Ulcerative Colitis Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.